The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.
More in Innovation
Trump’s ‘Morally Binding’ AI ‘Accord,’ the Rise of AI Agents, and Extremists on the Ballot
October 1, 2026
Experience What It’s Like to Travel in the Occupied West Bank
October 1, 2026
Tim Heidecker Is Bringing His Joe Rogan Parody Show to The Onion
October 1, 2026
The Best Early Amazon Echo Deals (and the Worst) Ahead of Prime Big Deal Days
October 1, 2026
Amazon Kindle, Paperwhite, and Colorsoft 2026: Specs, Price, Release Date
October 1, 2026
What’s the Best Kindle of 2026 (So Far)?
October 1, 2026
Latest News
Lyft is paying $272.5M to settle lawsuit over how it classified drivers
October 1, 2026
Kevin Mandia’s new ‘agent swarm’ security startup Armadin raises $255.5M at $2.5B valuation
October 1, 2026
Musk’s AI chatbot Grok reportedly encouraged Trump to capture Venezuela’s president
October 1, 2026
NASA Awards Enterprise Logistics Support Services Agreements
October 1, 2026
The FlashForge AD5X Multi-Color 3D Printer Drops to Just $220 Shipped at AliExpress
October 1, 2026
We Build LEGO SpongeBob SquarePants Bikini Bottom: a F.U.N. Build for Nostalgic Adults
October 1, 2026